Chronic Obstructive Pulmonary Disease in Cameroon: Prevalence and Predictors-A Multisetting Community-Based Study.


Journal

Pulmonary medicine
ISSN: 2090-1844
Titre abrégé: Pulm Med
Pays: Egypt
ID NLM: 101558762

Informations de publication

Date de publication:
2023
Historique:
received: 28 03 2023
revised: 22 08 2023
accepted: 01 09 2023
medline: 25 9 2023
pubmed: 22 9 2023
entrez: 22 9 2023
Statut: epublish

Résumé

Little is known concerning chronic obstructive pulmonary disease (COPD) in Sub-Saharan Africa (SSA), where the disease remains underdiagnosed. We aimed to estimate its prevalence in Cameroon and look for its predictors. Adults aged 19 years and older were randomly selected in 4 regions of Cameroon to participate in a cross-sectional community-based study. Data were collected in the participant's home or place of work. Spirometry was performed on selected participants. COPD was defined as the postbronchodilator forced expiratory volume in 1 second/forced vital capacity ratio (FEV1/FVC) < lower limit of normal, using the global lung initiative (GLI) equations for Black people. Binomial logistic regression was used to seek COPD-associated factors. The strength of the association was measured using the adjusted odds ratio (aOR). A total of 5055 participants (median age (25 The prevalence of COPD was relatively low. Alternative risk factors such as biomass fuel exposure, history of tuberculosis, and asthma were confirmed as predictors.

Identifiants

pubmed: 37736149
doi: 10.1155/2023/1631802
pmc: PMC10511289
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1631802

Informations de copyright

Copyright © 2023 Massongo Massongo et al.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

J Korean Med Sci. 2011 Feb;26(2):268-73
pubmed: 21286020
Lancet. 2007 Sep 1;370(9589):741-50
pubmed: 17765523
Am J Respir Crit Care Med. 2016 Jul 1;194(1):67-76
pubmed: 26788760
Curr Opin Allergy Clin Immunol. 2012 Feb;12(1):82-90
pubmed: 22157154
J Glob Health. 2015 Dec;5(2):020415
pubmed: 26755942
J AIDS Clin Res. 2015 May;6(5):
pubmed: 26236557
Am J Respir Crit Care Med. 1995 Sep;152(3):1107-36
pubmed: 7663792
Scand J Work Environ Health. 1989 Jun;15(3):188-94
pubmed: 2781248
Int J Chron Obstruct Pulmon Dis. 2012;7:457-94
pubmed: 22927753
Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76
pubmed: 11316667
Chest. 2011 Apr;139(4):752-763
pubmed: 20884729
Expert Rev Respir Med. 2018 Mar;12(3):227-237
pubmed: 29298106
PLoS One. 2012;7(5):e37978
pubmed: 22662259
Lancet. 2009 Aug 29;374(9691):733-43
pubmed: 19716966
Prim Care Respir J. 2013 Sep;22(3):300-5
pubmed: 23817677
Allergy. 2009 Jul;64(7):1061-7
pubmed: 19210360
Int Arch Occup Environ Health. 1992;63(7):503-7
pubmed: 1577530
BMC Res Notes. 2016 Feb 25;9:124
pubmed: 26917543
Respirology. 2011 Oct;16(7):1111-8
pubmed: 21801277
Eur Respir J. 2007 Dec;30(6):1180-5
pubmed: 17804445
Int J Tuberc Lung Dis. 2013 May;17(5):583-9
pubmed: 23394105
Thorax. 2014 May;69(5):465-73
pubmed: 24353008
BMC Pulm Med. 2018 Jan 19;18(1):11
pubmed: 29351754
Arch Public Health. 2015 Dec 21;73:47
pubmed: 26693277
Int J Tuberc Lung Dis. 2013 Feb;17(2):270-4
pubmed: 23317965
Int J Occup Environ Health. 2015;21(1):61-5
pubmed: 25384259
BMC Pulm Med. 2019 Oct 17;19(1):181
pubmed: 31623601
Am J Ind Med. 2008 Sep;51(9):640-7
pubmed: 18566985
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
COPD. 2020 Jun;17(3):297-305
pubmed: 32462945
J Glob Health. 2019 Jun;9(1):010434
pubmed: 31217961
Int J Tuberc Lung Dis. 2011 Mar;15(3):391-8
pubmed: 21333109
Eur Respir J. 2018 Jan 31;51(2):
pubmed: 29386343
Int J Tuberc Lung Dis. 2004 Mar;8(3):369-76
pubmed: 15139477
Eur Respir J. 2012 Jun;39(6):1343-53
pubmed: 22183479
PLoS Med. 2006 Nov;3(11):e442
pubmed: 17132052
Respir Med. 2015 Feb;109(2):247-54
pubmed: 25538018
Int J Environ Res Public Health. 2020 Aug 13;17(16):
pubmed: 32823587
Arch Med Res. 2012 Feb;43(2):159-65
pubmed: 22475778
Chest. 2007 Nov;132(5):1608-14
pubmed: 17998360
Ethn Dis. 2002 Fall;12(4):S3-107-13
pubmed: 12477165
Lancet Glob Health. 2015 Jan;3(1):e44-51
pubmed: 25539969
Chest. 2008 Feb;133(2):343-9
pubmed: 17951621

Auteurs

Massongo Massongo (M)

Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.

Adamou Dodo Balkissou (AD)

Faculty of Medicine and Biomedical Sciences, University of Ngaoundéré, Garoua, Cameroon.

Laurent-Mireille Endale Mangamba (LM)

Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon.
Laquintinie Hospital, Douala, Cameroon.

Virginie Poka Mayap (V)

Jamot Hospital, Yaoundé, Cameroon.

Marie Elisabeth Ngah Komo (ME)

Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Jamot Hospital, Yaoundé, Cameroon.

Abdou Wouoliyou Nsounfon (AW)

Central Hospital of Yaoundé, Yaoundé, Cameroon.

Alain Kuaban (A)

Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Jamot Hospital, Yaoundé, Cameroon.

Eric Walter Pefura Yone (EW)

Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Jamot Hospital, Yaoundé, Cameroon.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH